Lucía Lourido

Lucía Lourido

Auto-generated profile, based on publicly available information

Lucía Lourido

Rheumatology Division, ProteoRed/ISCIII Proteomics Group, INIBIC, Hospital Universitario de A Coruña, A Coruña 15006, Spain

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2015 in BioTech
Verified
Journal Article
Open access
PDF file
Paula DíezPaula Díez
Paula Díez
MGMaría González-González
María González-González
LLLucía Lourido
Lucía Lourido
RDRosa M. Dégano
Rosa M. Dégano
NINieves Ibarrola
Nieves Ibarrola
Manuel FuentesManuel Fuentes
Manuel Fuentes
Nucleic Acid Programmable Protein Arrays (NAPPA) have emerged as a powerful and innovative technology for the screening of biomarkers and the study of protein-protein interactions, among others possible applications. The principal advantages are the high specificity and sensitivity that this platform offers. Moreover, compared to conventional protein microarrays, NAPPA technology avoids the necessity of protein purification, which is expensive and time-consuming, by substituting expression in situ with an in vitro transcription/translation kit. In summary, NAPPA arrays have been broadly employed in different studies improving knowledge about diseases and responses to treatments. Here, we review the principal advances and applications performed using this platform during the last years.